137 results
Page 2 of 7
8-K
EX-10.1
m7ephmp3kk86m4 bn
22 Jun 22
BeiGene Announces Acceptance of Supplemental Biologics License Application in China for Anti-PD-1 Inhibitor Tislelizumab
5:07pm
8-K
EX-10.1
y7le c5jm68e6ljd
22 Feb 22
BRUKINSA was granted approval by the European Commission for the treatment of Waldenström’s macroglobulinemia in November 2021
4:10pm